(Q63835320)

English

Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia

clinical trial

Statements

A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, 28 Day, Three-arm, Parallel Group Study of A0001 in the Treatment of Subjects With Friedreich's Ataxia (English)
0 references
0 references
0 references
0 references
December 2009
0 references
February 2011
0 references
42
0 references
18 year
0 references
60 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit